Walleye Capital
UTHR icon

Walleye Capital’s United Therapeutics UTHR Stock Holding History

Walleye Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.6M Sell
2,700
-4,600
-63% -$2.29M 0.01% 1651
2025
Q4 		$3.56M Buy
7,300
+7,000
+2,333% +$3.26M 0.01% 1409
2025
Q3 		$126K Buy
+300
New +$101K ﹤0.01% 3592
2025
Q1 		– Sell
-700
Closed -$247K – 5169
2024
Q4 		$247K Sell
700
-12,800
-95% -$4.7M ﹤0.01% 3593
2024
Q3 		$4.84M Buy
13,500
+3,300
+32% +$1.11M 0.01% 1198
2024
Q2 		$3.25M Buy
10,200
+3,700
+57% +$979K 0.01% 1651
2024
Q1 		$1.49M Buy
6,500
+4,300
+195% +$970K ﹤0.01% 2209
2023
Q4 		$484K Sell
2,200
-700
-24% -$161K ﹤0.01% 2976
2023
Q3 		$655K Buy
2,900
+2,400
+480% +$553K ﹤0.01% 2603
2023
Q2 		$110K Buy
+500
New +$111K ﹤0.01% 3388
2023
Q1 		– Sell
-3,900
Closed -$1.08M – 4394
2022
Q4 		$1.08M Buy
3,900
+3,400
+680% +$858K 0.02% 956
2022
Q3 		$105K Buy
+500
New +$112K ﹤0.01% 2405
2020
Q1 		– Sell
-8,700
Closed -$766K – 1697
2019
Q4 		$766K Buy
8,700
+5,000
+135% +$440K 0.05% 509
2019
Q3 		$295K Buy
3,700
+1,900
+106% +$153K 0.02% 988
2019
Q2 		$141K Buy
1,800
+300
+20% +$28.1K 0.02% 1104
2019
Q1 		$176K Buy
+1,500
New +$175K 0.03% 818

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Walleye Capital's UTHR Position: Q1 2026 in Review

Walleye Capital reduced its United Therapeutics (UTHR) stake by 79% in Q1 2026, selling an estimated $3.94M and leaving 2,166 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #1854.

Walleye Capital first reported a position in UTHR in Q1 2019 and has held it in 20 quarters since. The position peaked at $13M in Q3 2022. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Walleye Capital held 2,166 shares of United Therapeutics worth $1.28M as of Q1 2026.
  • Walleye Capital sold 7,919 United Therapeutics shares in Q1 2026, an estimated $3.94M.
  • United Therapeutics made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1854 holding.
  • Walleye Capital first reported a position in United Therapeutics in Q1 2019 and has held it in 20 quarters since.
  • Walleye Capital's United Therapeutics position peaked at $13M in Q3 2022.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.